Industry Science

Trabectedin + pegylated liposomal doxorubicin (PLD) is back!

Published in: Volume 7 / Year 2013 / Issue 1
Page: 22-23

Abstract:Oncologists have welcomed the return of pegylated liposomal doxorubicin (PLD) after an 18-month halt in production. Patients with recurrent ovarian cancer benefit from PLD as monotherapy or in combination with… Read More »

New stability studies for fludarabine according to the European Pharmacopoeia 7.0

Page: 14-15

Abstract:New stability tests of fludarabine in standard, therapeutically relevant concentrations were performed. A new HPLC method was used which separates all related substances mentioned in the European Pharmacopoeia. Stability could… Read More »

Go Back Print
Webdesign by I2CT